A Performance Evaluation of Commercial Fibrinogen Reference Preparations and Assays for Clauss and PT-derived Fibrinogen

Summary The wide availability of fibrinogen estimations based on the prothrombin time (PT-Fg) has caused concern about the variability and clinical utility of fibrinogen assays. In a multi-centre study, we investigated fibrinogen assays using various reagents and analysers. Clauss assays generally gave good agreement, although one reagent gave 15–30% higher values in DIC and thrombolysis. Two commercial reference preparations had much lower potencies than the manufacturers declared, and plasma turbidity influenced parallelism in some Clauss assays. PT-Fg assays gave higher values than Clauss and showed calibrant dependent effects, the degree of disparity correlating with calibrant and test sample turbidity. Analyser and thromboplastin dependent differences were noted. The relationship between Clauss and PT-Fg assays was sigmoid, and the plateau of maximal PT-Fg differed by about 2 g/l between reagents. ELISA and immunonephelometric assays correlated well, but with a high degree of scatter. Antigen levels were higher than Clauss, but slightly lower than PT-Fg assays, which appeared to be influenced by degraded fibrinogen. Clauss assays are generally reproducible between centres, analysers and reagents, but PT-Fg assays are not reliable in clinical settings.

[1]  P. Gaffney,et al.  A Collaborative Study to Establish the 2nd International Standard for Fibrinogen, Plasma , 2000, Thrombosis and Haemostasis.

[2]  G. Lowe,et al.  Use Of Fibrinogen and Fibrin D-Dimer in Prediction of Arterial Thrombotic Events , 1999, Thrombosis and Haemostasis.

[3]  I. Mackie,et al.  Prothrombin time derived fibrinogen determination on Sysmex CA-6000. , 1998, Journal of clinical pathology.

[4]  R. De Cristofaro,et al.  Measurement of plasma fibrinogen concentration by the prothrombin-time-derived method: applicability and limitations , 1998, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[5]  P. Elwood,et al.  The relative power of heat‐precipitation nephelometric and clottable (Clauss) fibrinogen in the prediction of ischaemic heart disease: the Caerphilly and Speedwell studies , 1998, British journal of haematology.

[6]  J. Hoffmann,et al.  Evaluation of an automated photometric fibrinogen assay , 1997, Blood Coagulation and Fibrinolysis.

[7]  M. Lansink,et al.  Effect of Oral Contraceptives on Haemostasis Variables , 1997, Thrombosis and Haemostasis.

[8]  S. Humphries,et al.  Gene-Environment Interaction in the Determination of Levels of Haemostatic Variables Involved in Thrombosis and Fibrinolysis , 1997, Thrombosis and Haemostasis.

[9]  M. Woodward,et al.  EPIDEMIOLOGY OF COAGULATION FACTORS, INHIBITORS AND ACTIVATION MARKERS: THE THIRD GLASGOW MONICA SURVEY I. ILLUSTRATIVE REFERENCE RANGES BY AGE, SEX AND HORMONE USE , 1997, British journal of haematology.

[10]  R. Schön,et al.  Comparison of a new automated kinetically determined fibrinogen assay with the 3 most used fibrinogen assays (functional, derived and nephelometric) in Austrian laboratories in several clinical populations and healthy controls. , 1995, Haemostasis.

[11]  I. Mackie,et al.  Inaccuracy of the 'derived' fibrinogen measurement. , 1994, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[12]  A. Tripodi,et al.  Results of a collaborative study for fibrinogen measurement. Evidence that the use of a common calibrator improves interlaboratory agreement , 1994, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[13]  R. Muche,et al.  Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS) , 1994, European journal of clinical investigation.

[14]  P. Gaffney,et al.  Collaborative Study of a Proposed International Standard for Plasma Fibrinogen Measurement , 1992, Thrombosis and Haemostasis.

[15]  S. Kitchen,et al.  A Comparison of Methods for the Measurement of Activated Factor VII , 1992, Thrombosis and Haemostasis.

[16]  P. Mannucci,et al.  Fibrinogen assays: a collaborative study of six different methods. C.I.S.M.E.L. Comitato Italiano per la Standardizzazione dei Metodi in Ematologia e Laboratorio. , 1991, Clinical chemistry.

[17]  B. Lämmle,et al.  How high is the true fibrinogen content of fibrinogen standards? , 1989, Thrombosis research.

[18]  A. Lombardi,et al.  Method for the determination of functional (clottable) fibrinogen by the new family of ACL coagulometers. , 1988, Thrombosis research.

[19]  J. Hoffmann,et al.  Automated nephelometry of fibrinogen: analytical performance and observations during thrombolytic therapy. , 1988, Clinical chemistry.

[20]  C. Greenberg,et al.  The effect of fibrin polymerization inhibitors on quantitative measurements of plasma fibrinogen. , 1987, American Journal of Clinical Pathology.

[21]  V Chantarangkul,et al.  EVALUATION OF A FULLY AUTOMATED CENTRIFUGAL ANALYSER FOR ITS PERFORMANCE OF HEMOSTASIS TESTS , 1987, Thrombosis and Haemostasis.

[22]  U. Becker,et al.  A functional photometric assay for plasma fibrinogen. , 1984, Thrombosis research.

[23]  E. Natelson,et al.  Rapid determination of fibrinogen by thrombokinetics. , 1974, American journal of clinical pathology.

[24]  D. J. Finney.  Statistical Method in Biological Assay , 1966 .

[25]  M. Verstraete,et al.  A rapid enzymatic method for assay of fibrinogen fibrin polymerization time (FPT test). , 1963, Clinica chimica acta; international journal of clinical chemistry.

[26]  A. Clauss,et al.  Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens , 1957 .

[27]  W. Nieuwenhuizen,et al.  Soluble fibrin and degradation products of fibrinogen (FgDP), fibrin (FbDP; D-dimer) and total of FgDP and FbDP (TDP) , 1999 .

[28]  R. Bertina,et al.  Laboratory Techniques in Thrombosis — a Manual , 1999, Springer Netherlands.

[29]  I.chanarin.  Laboratory haematology:an account of laboratory techniques , 1989 .

[30]  J. V. van Wersch,et al.  Use of a centrifugal analyzer for a chromogenic prothrombin time, a chromogenic activated partial thromboplastin time and a kinetic fibrinogen assay in a routine hospital laboratory. , 1987, Haemostasis.

[31]  J. V. Wersch,et al.  Use of a Centrifugal Analyzer for a Chromogenic Prothrombin Time, a Chromogenic Activated Partial Thromboplastin Time and a Kinetic Fibrinogen Assay in a Routine Hospital Laboratory , 1987 .

[32]  J. Martinou,et al.  [Evaluation of the performance of an automatic coagulation tester: the Electra 700]. , 1985, Nouvelle revue francaise d'hematologie.

[33]  K. Jacobsson.  I. Studies on the determination of fibrinogen in human blood plasma. II. Studies on the trypsin and plasmin inhibitors in human blood serum. , 1955, Scandinavian journal of clinical and laboratory investigation.